<DOC>
	<DOCNO>NCT00002290</DOCNO>
	<brief_summary>This double-blind , placebo-controlled study design determine long-term safety efficacy concurrent oral Retrovir / Zovirax ( AZT ACV ) therapy oral AZT therapy alone , treatment early symptomatic HIV infection . Efficacy evaluate monitor incidence , severity , time development opportunistic infection manifestation advance symptomatic HIV infection . The effect combination single AZT therapy immune function viral replication also evaluate . Study participant monitor evidence toxicity intolerance concurrent AZT / ACV administration AZT therapy alone .</brief_summary>
	<brief_title>The Safety Effectiveness Zidovudine Plus Acyclovir Patients With Early HIV Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<criteria>Inclusion Criteria Patients must : Early AIDS relate complex ( ARC ) . Willingness follow original study center duration trial ( 96 week ) . Ability give inform consent . Patients may associate lymphadenopathy ( lymph node great equal 1 cm two noncontiguous area ) . Exclusion Criteria Coexisting Condition : Patients follow exclude : Concurrent neoplasm basal cell carcinoma skin situ carcinoma cervix . Fever &gt; 102 degree F persist 14 consecutive day 15 day 30day interval , present entry . Severe malabsorption ( evidenced persistent diarrhea great 4 week duration = &gt; 6 loose stool per day accompany significant weight loss ) . Concurrent Medication : Excluded : Acyclovir ( ACV ) therapy chronic recurrent herpes simplex . Patients AIDSdefining indicator disease outline CDC surveillance definition AIDS include opportunistic infection neoplasm , HIV neurologic disease , AIDS dementia `` wasting syndrome '' exclude . Prior Medication : Excluded within 4 week study entry : Any experimental therapy . Drugs cause significant bone marrow suppression . Rifampin rifampin derivative . Cytolytic chemotherapy . Drugs cause significant nephrotoxicity hepatotoxicity . Immunomodulating agent , include steroid , interferon , Isoprinosine , immunoglobulin interleukin 2 . Excluded within 8 week study entry : Antiretroviral agent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 1990</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Acyclovir</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Zidovudine</keyword>
</DOC>